Corient Private Wealth LP Acquires Shares of 12,554 Cabot Corporation $CBT

Corient Private Wealth LP acquired a new stake in shares of Cabot Corporation (NYSE:CBT) in the 2nd quarter, HoldingsChannel reports. The fund acquired 12,554 shares of the specialty chemicals company’s stock, valued at approximately $1,140,000.

A number of other institutional investors also recently modified their holdings of the company. Northwestern Mutual Wealth Management Co. purchased a new stake in shares of Cabot in the 2nd quarter worth about $33,000. Rothschild Investment LLC increased its position in shares of Cabot by 170.4% during the fourth quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock valued at $27,000 after buying an additional 259 shares during the period. Geneos Wealth Management Inc. increased its position in shares of Cabot by 409.0% during the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock valued at $38,000 after buying an additional 364 shares during the period. Global Retirement Partners LLC lifted its stake in shares of Cabot by 1,606.9% in the 4th quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock valued at $33,000 after purchasing an additional 466 shares during the period. Finally, Danske Bank A S purchased a new position in shares of Cabot in the 3rd quarter valued at approximately $38,000. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, CEO Sean Keohane sold 134,895 shares of the business’s stock in a transaction dated Friday, August 28th. The stock was sold at an average price of $85.00, for a total value of $11,466,075.00. Following the transaction, the chief executive officer directly owned 404,134 shares in the company, valued at $34,351,390. The trade was a 25.03% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders sold 229,597 shares of company stock worth $19,646,746 over the last quarter. 3.08% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on CBT. Truist Financial set a $100.00 price objective on Cabot in a research note on Wednesday, August 5th. JPMorgan Chase & Co. upped their price target on Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a report on Friday, August 7th. Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research note on Friday, August 21st. Wall Street Zen raised Cabot from a “hold” rating to a “buy” rating in a report on Sunday, August 9th. Finally, Mizuho upped their price objective on Cabot from $80.00 to $90.00 and gave the company a “neutral” rating in a research report on Thursday, June 25th. Two research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $89.00.

Cabot Stock Up 0.3%

Shares of CBT stock opened at $81.47 on Friday. The company has a current ratio of 1.47, a quick ratio of 0.97 and a debt-to-equity ratio of 0.48. Cabot Corporation has a 12 month low of $58.33 and a 12 month high of $94.53. The stock has a market cap of $4.21 billion, a P/E ratio of 22.95, a P/E/G ratio of 10.66 and a beta of 0.83. The company has a 50 day simple moving average of $86.67 and a two-hundred day simple moving average of $81.40.

Cabot (NYSE:CBT) last issued its quarterly earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share for the quarter, topping the consensus estimate of $1.66 by $0.01. The business had revenue of $982.00 million for the quarter, compared to analysts’ expectations of $943.16 million. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The company’s revenue was up 6.4% compared to the same quarter last year. During the same quarter last year, the company posted $1.90 EPS. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. On average, research analysts expect that Cabot Corporation will post 6.35 earnings per share for the current year.

Cabot Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 28th will be issued a $0.4725 dividend. This represents a $1.89 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend is Friday, August 28th. Cabot’s dividend payout ratio is currently 53.24%.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.